Skip to content
October 10, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive 2026 Survivorship Webinar Series
  • Patient Advocacy and Support

Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive 2026 Survivorship Webinar Series

Ammar Sabilarrohman October 10, 2026 8 minutes read
navigating-the-new-normal-breast-cancer-canada-announces-comprehensive-2026-survivorship-webinar-series

TORONTO, ON – As the medical community continues to make strides in the early detection and acute treatment of breast cancer, the focus of patient care is increasingly shifting toward the "fourth trimester" of oncology: survivorship. Recognizing the complex hurdles that remain after the final chemotherapy infusion or radiation session, Breast Cancer Canada has unveiled an expansive three-part webinar series for October 2026.

The series, titled with a focus on holistic recovery, aims to bridge the gap between clinical remission and long-term wellness. By bringing together registered dietitians, physical advocates, and emotional resilience coaches, the initiative addresses the multifaceted reality of life after a diagnosis. The program highlights a critical truth in modern oncology: while treatment may end, the journey toward physical, nutritional, and emotional restoration is often just beginning.

Main Facts: A Holistic Approach to Post-Treatment Care

The October 2026 webinar series is structured as a progressive journey, moving from the internal (nutrition and biochemistry) to the external (physical changes and lymphedema) and finally to the psychological (emotional identity and reintegration).

The Expert Panel

Breast Cancer Canada has curated a panel of specialists who bring both professional expertise and lived experience to the platform.

  • Jean LaMantia, RD: A registered dietitian and cancer survivor, LaMantia specializes in evidence-based oncology nutrition, cutting through the noise of "superfood" myths to provide actionable metabolic support.
  • Voula Pantelis: Representing AMOENA Canada, Pantelis is a seasoned breast cancer advocate focusing on the physical solutions for post-surgical life, from compression garments to body image restoration.
  • Jacqueline Beatty: A survivor and the founder of Rising Lotus, Beatty introduces the "Root to Rise" framework, a psychological methodology designed to help survivors navigate the identity shift that occurs when they are no longer "patients."

Core Objectives

The primary goal of the series is to provide evidence-based guidance in an era of information overload. Patients often report feeling "dropped off a cliff" once active treatment ends; these sessions are designed to serve as a safety net, offering tools for weight management, bone health, scar care, and emotional regulation.

Chronology: The Three Pillars of the 2026 Series

The series is scheduled to take place every Thursday throughout the month of October, coinciding with Breast Cancer Awareness Month. Each session is strategically timed to build upon the previous week’s insights.

October 8, 2026: The Nutritional Foundation

The series kicks off with "Nutrition After Breast Cancer," led by Jean LaMantia. This session addresses the immediate biological needs of a body recovering from the rigors of treatment.

The focus here is twofold: maintenance and mitigation. LaMantia will delve into the science of protein synthesis for muscle maintenance—a critical factor for survivors who may have experienced sarcopenia (muscle loss) during treatment. Furthermore, the session addresses the specific nutritional requirements of those undergoing endocrine therapy. Because many breast cancer survivors remain on hormone-blocking medications for five to ten years, managing bone density and gut health becomes a long-term priority.

October 15, 2026: Physical Restoration and Advocacy

The second installment, "Living Well: Physical Effects Beyond Breast Cancer Treatment," features Voula Pantelis. This session transitions from the internal to the external, focusing on the permanent or long-term physical alterations caused by surgery and radiation.

Key topics include the management of lymphedema—a chronic swelling that can occur after lymph node removal—and the nuances of scar tissue management. Pantelis will also provide practical advice for "living well" in a changed body, including travel considerations for those wearing compression sleeves and the psychological impact of choosing prosthetics versus flat closure.

October 22, 2026: Emotional Resilience and "Root to Rise"

The final session, "Moving Emotions Forward: Root to Rise," led by Jacqueline Beatty, tackles the often-invisible scars of cancer. As patients transition back to work and "normal" life, they frequently encounter a sense of alienation.

Beatty’s "Root to Rise" framework focuses on grounding oneself in new values. This session explores the "fear of recurrence"—a psychological phenomenon that can paralyze survivors—and provides strategies for setting boundaries in personal and professional relationships as they navigate their post-cancer identity.

Supporting Data: The Science of Survivorship

The necessity of this webinar series is backed by evolving data regarding breast cancer outcomes and the long-term side effects of treatment.

The Endocrine Therapy Challenge

Approximately 70-80% of breast cancers are hormone-receptor-positive. For these patients, the end of "active" treatment (surgery/chemo) is merely the start of long-term endocrine therapy (such as Tamoxifen or Aromatase Inhibitors). Data suggests that these medications, while life-saving, significantly increase the risk of osteoporosis and joint pain. The inclusion of bone health and nutrition in the October 8 session is a direct response to the fact that nearly 20% of women on aromatase inhibitors experience significant bone density loss within the first few years of treatment.

The Lymphedema Burden

Lymphedema remains one of the most significant physical concerns post-surgery. Statistics indicate that between 20% and 30% of breast cancer survivors will develop lymphedema. The October 15 session’s focus on compression and physical activity is vital, as early intervention and specialized exercises have been shown to reduce the severity of swelling by up to 50%.

The Psychological Gap

According to recent psychosocial oncology studies, nearly 60% of breast cancer survivors report "moderate to high" levels of fear regarding recurrence. Furthermore, the transition back to the workplace is cited as a major stressor for 40% of survivors. Jacqueline Beatty’s session on emotional transitions addresses these statistics by focusing on "emotional regulation" and "identity reconnection," which are proven metrics for improving the Quality of Life (QoL) scores in post-cancer patients.

Official Responses: Perspectives from the Experts

The speakers for the 2026 series emphasize that survivorship is not a passive state but an active practice.

Jean LaMantia, RD, emphasizes the danger of misinformation. "Nutrition advice can be overwhelming, particularly when online information ranges from evidence-based guidance to unsupported claims," she notes. Her approach focuses on "building balanced meals without unnecessary restrictions," highlighting that a survivor’s diet should be about nourishment and empowerment, not fear-based deprivation.

Voula Pantelis views physical advocacy as a gateway to confidence. "Treatment may end, but physical changes can continue," she explains. Her goal is to move the conversation beyond the clinical setting and into the lifestyle space, addressing how survivors can return to physical activity and travel while managing the lingering discomfort of surgery.

Jacqueline Beatty speaks to the profound shift in priority that follows a diagnosis. "The transition beyond treatment can bring complicated emotions. Uncertainty, changing priorities, and questions about identity can all become part of navigating life after breast cancer." Through the "Root to Rise" framework, she aims to help survivors find a "new normal" that is rooted in their personal values rather than their medical history.

Implications: A Shift in the Oncology Landscape

The 2026 webinar series by Breast Cancer Canada signals a broader shift in the Canadian healthcare landscape. It moves away from a purely "pathogenic" model—which focuses only on the disease—and toward a "salutogenic" model, which focuses on the factors that support human health and well-being.

Bridging the Care Gap

One of the most significant implications of this series is its accessibility. By hosting these sessions via Zoom, Breast Cancer Canada is addressing the geographical disparities in cancer support. Patients in rural or underserved areas, who may not have access to specialized oncology dietitians or lymphedema clinics, can receive the same high-level expertise as those in major urban centers.

Redefining "Success" in Cancer Treatment

Traditionally, success in oncology was measured by five-year survival rates. However, as survival rates improve, the definition of success is expanding to include the quality of those surviving years. By addressing gut health, body image, and emotional boundaries, this series acknowledges that surviving cancer is only the first step; thriving after cancer requires a different set of tools entirely.

Future Directions for Patient Advocacy

The inclusion of topics like "fear of recurrence" and "returning to work" suggests that patient advocacy groups are becoming more attuned to the socioeconomic and psychological realities of the disease. This series sets a precedent for future programming, suggesting that "breast cancer awareness" must evolve into "breast cancer support" that lasts a lifetime.

As October 2026 approaches, the medical and survivor communities look toward these sessions as a roadmap for the future. By integrating nutrition, physical therapy, and emotional intelligence, Breast Cancer Canada is ensuring that survivors are not just living longer, but living better.


Registration Information:

  • Nutrition After Breast Cancer: Slides available via Breast Cancer Canada archives.
  • Living Well: Registration via Zoom (October 15).
  • Moving Emotions Forward: Registration via Zoom (October 22).

About the Author

Ammar Sabilarrohman

Author

View All Posts

Post navigation

Previous: Bridging Crises: WHO Director-General Strengthens Global Health Partnerships During Landmark Visit to Jordan
Next: A New Standard in Metastatic Care: FDA Approves Tucatinib Combination as First-Line Maintenance for HER2-Positive Breast Cancer

Related Stories

navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-deep-dive-into-emerging-research
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

Jia Lissa October 10, 2026
global-landmarks-to-glow-teal-green-and-pink-the-2026-push-to-fund-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research

Nana October 10, 2026
Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo
  • Patient Advocacy and Support

FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Iffa Jayyana October 10, 2026

Recent Posts

  • Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth
  • Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib
  • Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research
  • Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research
  • FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unmasking-cancers-master-manipulator-ou-research-reveals-how-aggressive-breast-tumors-hijack-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth

Evan Lee Salim October 10, 2026
alumis-poised-to-enter-crowded-psoriasis-market-with-promising-tyk2-inhibitor-envudeucitinib
  • Medical Research and Clinical Trials

Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib

Nana Wu October 10, 2026
navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-deep-dive-into-emerging-research
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

Jia Lissa October 10, 2026
global-landmarks-to-glow-teal-green-and-pink-the-2026-push-to-fund-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research

Nana October 10, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.